Prednisone
Idiopathic Pulmonary Fibrosis
Fondation Hôpital Saint-JosephSmall moleculePhase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 51/ 100
- Competitive Position
- 95/ 100
Competitive context
107 Active assets in the Idiopathic Pulmonary Fibrosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Pirfenidone Endeavor Biomedicines, Inc. | Phase 4 | A |
Acetylcysteine Endeavor Biomedicines, Inc. | Phase 4 | BBB |
Nintedanib Mannkind Corporation | Phase 4 | BBB |
hsk44459 Haisco Pharmaceutical Group Co., Ltd. | Phase 3 | BB |
Nerandomilast Boehringer Ingelheim | Phase 3 | BB |
View all 50 →
Same molecule, other indications
Prednisone is also rated in:
peripheral T-cell lymphoma, not otherwise specifiedActive
BBB
Indicative · Phase 4
74 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →